TITAN Project: Microfluidic and Sensing Tools for Immunotherapy
Authors:
- Maria Serena ChiriacòMCMaria Serena Chiriacò
- Elisabetta PrimiceriEPElisabetta Primiceri
- Antonio TurcoAntonio Turco
- Valeria GarzarelliVGValeria Garzarelli
- Giulia SicilianoGSGiulia Siciliano
- Alessia FoscariniAFAlessia Foscarini
- Ahmed AlsadigAAAhmed Alsadig
- Annunziata CarbonaraACAnnunziata Carbonara
- Benedetta StamponeBSBenedetta Stampone
- Gianluca TrottaGianluca Trotta
- Marco CeredaMCMarco Cereda
- Marco de TullioMTMarco de Tullio
Open Access
- 10 May 2024
- conference paper
- Published by MDPI AG in Proceedings
- Vol. 97 (1) , 214
Abstract
The TITAN project aims to improve immunotherapy, targeting the efficiency of methods to obtain genetically engineered T cells. Immunotherapy has achieved great success in clinical trials, but it is currently very expensive in terms of time required for analysis, reagents, and samples. TITAN aims to the continuous sampling of critical quality attributes, in order to quickly recognize deviations from the desired range and take appropriate corrective actions on process parameters for an optimal outcome. To achieve its aims, TITAN is currently developing microfluidic and sensing tools for the accurate and efficient real-time monitoring of the T cells amplification process.Keywords
Funding Information
- “TITAN Nanotecnologie per l’immunoterapia dei tumori” (ARS01_00906, 2014-2020 Azione II-OS 1.b)
- FESR Programme PON “Ricerca e Innovazione” (ARS01_00906, 2014-2020 Azione II-OS 1.b)
This publication has 2 references indexed in Scilit: